The peptide is not damaged
A licensed healthcare provider reviews your medical intake form and determines eligibility
One small study found that about 78% of participants lost at least 5% of their body weight after 3 months, and many of the responders reported more regular cycles by 6 months
Buckley ST, Bkdal TA, Vegge A, Maarbjerg SJ, Pyke C, Ahnfelt-Rnne J, et al
The approval of semaglutide means that it can be easily accessed by patients and healthcare providers, facilitating timely treatment decisions
The blockbuster success of Novo Nordisks Ozempic/Wegovy and Lillys Mounjaro/Zepbound, all injectables, have put GLP-1/GIP agonists on the map, but will new oral drugs be a game-changer